Webinars

• Successful Outcomes in Patients with Exudative Age Related Macular Degeneration

  Sponsored By: KCY Education Group

  Optimize the experience for your patients with Age Related Macular Degeneration (AMD) by understanding dosing frequencies, utilizing the treat-and-extend approach, and developing a standard follow-up protocol.

  Recorded on February 28, 2018

• Evidence-based Management of Diabetic Eye Diseases Webinar Series (November 3, 2015)

  Jointly Provided by: PentaVision, Dannemiller and Retinal Physician
  
  Kimberly Drenser, MD, PHD and Seenu M. Hariprasad, MD
  Recorded on November 3, 2015

• Evidence-based Management of Diabetic Eye Diseases Webinar Series (October 22, 2015)

  Jointly Provided by: PentaVision, Dannemiller and Retinal Physician
  
  Elias Reichel, MD and Seenu M. Hariprasad, MD
  Recorded on October 22, 2015

• Evidence-based Management of Diabetic Eye Diseases Webinar Series (September 21, 2015)

  Jointly Provided by: PentaVision, Dannemiller and Retinal Physician
  
  Sharon Fekrat, MD and Seenu M. Hariprasad, MD
  Recorded on September 21, 2015

• High-Frequency Ultrasound in the Era of OCT

  Sponsored By: Ellex

  • Enhancing the Unique Role of Hi-frequency Ultrasound in an Era of OCT.
  • Recent advances in technology and a simple to perform, patient-friendly technique make anterior ultrasound a great choice to supplement posterior segment imaging.
  • Real Time imaging of Anterior and Posterior Diagnostic B-Scan represent major improvements to this critical clinical imaging procedure for both opaque and clear media.

  
  Recorded on September 29, 2015

• Expanding Opportunities for Vitreoretinal Surgeons: The Next Generation of VersaVIT

  Sponsored By: Synergetics

  • The need for VersaVIT 2.0 in your facility
  • Understanding system capabilities
  • Driving surgical efficiencies in your operating room
  • Clinical experiences with VersaVIT 2.0

  
  Recorded on September 16, 2014

• Ocriplasmin Clinical Update

  Sponsored By: Thrombogenics

  • Optimizing Treatment Outcomes and Real World Experience
  • Macular Adverse Events and Lens Findings
  • OCT Changes
  • Visual Function Adverse Events
  • Ongoing safety initiatives